Fresenius Medical Care AG & Co. (Pref) (FME) Given a €92.00 Price Target at Credit Suisse Group

Credit Suisse Group set a €92.00 ($106.98) price target on Fresenius Medical Care AG & Co. (Pref) (ETR:FME) in a research report sent to investors on Monday. The firm currently has a buy rating on the stock.

Several other research firms have also recently issued reports on FME. Goldman Sachs Group, Inc. (The) set a €97.00 ($112.79) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a report on Monday, October 30th. Deutsche Bank AG set a €84.00 ($97.67) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a neutral rating in a report on Tuesday, August 8th. J P Morgan Chase & Co set a €95.40 ($110.93) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a report on Thursday, November 2nd. Independent Research GmbH set a €88.00 ($102.33) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a neutral rating in a report on Friday. Finally, Berenberg Bank set a €95.60 ($111.16) price target on Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a report on Thursday, November 2nd. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and ten have assigned a buy rating to the company. The stock currently has a consensus rating of Buy and an average target price of €89.28 ($103.81).

Shares of Fresenius Medical Care AG & Co. (ETR FME) traded down €0.20 ($0.23) during trading hours on Monday, hitting €84.19 ($97.90). The stock had a trading volume of 602,664 shares, compared to its average volume of 554,980. Fresenius Medical Care AG & Co. has a 52 week low of €70.69 ($82.20) and a 52 week high of €89.22 ($103.74).

ILLEGAL ACTIVITY NOTICE: This report was originally reported by Community Financial News and is owned by of Community Financial News. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.com-unik.info/2017/11/07/fresenius-medical-care-ag-92-00-price-target-at-credit-suisse-group.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

What are top analysts saying about Fresenius Medical Care AG & Co. (Pref)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius Medical Care AG & Co. (Pref) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit